Pub Date : 2024-03-01DOI: 10.1016/j.inpm.2023.100381
Marshall Devor
Pain in osteoarthritis (OA) results from erosion of joint cartilage, resulting in bone contacting bone without an intervening cushion. The periosteum, including its nociceptive innervation, ends at the border of the cartilage. No other innervated tissue is present between the denuded articular bone ends that could serve as a neuronal pathway to carry a bone-on-bone pain signal to the brain. The pain signaling pathway must therefore originate in afferent axons with electrogenic nociceptive sensory endings that reside within the bone itself, specifically in the opposing surfaces of epiphyseal subchondral bone. Selective ablation of this intrinsic nerve pathway, using any of a variety of approaches, is expected to permanently eliminate OA pain.
骨关节炎(OA)的疼痛源于关节软骨的侵蚀,导致骨与骨之间没有缓冲垫。骨膜(包括其痛觉神经)止于软骨边界。在变性的关节骨末端之间没有其他神经支配组织可以作为神经元通路,将骨与骨之间的疼痛信号传递到大脑。因此,疼痛信号通路必须起源于具有电源性痛觉末梢的传入轴突,这些末梢位于骨本身,特别是骺软骨下骨的对立面。使用各种方法选择性地消融这一内在神经通路,有望永久消除 OA 疼痛。
{"title":"Pain in osteoarthritis: Driven by intrinsic rather than extrinsic joint afferents and why this should impact treatment","authors":"Marshall Devor","doi":"10.1016/j.inpm.2023.100381","DOIUrl":"https://doi.org/10.1016/j.inpm.2023.100381","url":null,"abstract":"<div><p>Pain in osteoarthritis (OA) results from erosion of joint cartilage, resulting in bone contacting bone without an intervening cushion. The periosteum, including its nociceptive innervation, ends at the border of the cartilage. No other innervated tissue is present between the denuded articular bone ends that could serve as a neuronal pathway to carry a bone-on-bone pain signal to the brain. The pain signaling pathway must therefore originate in afferent axons with electrogenic nociceptive sensory endings that reside within the bone itself, specifically in the opposing surfaces of epiphyseal subchondral bone. Selective ablation of this intrinsic nerve pathway, using any of a variety of approaches, is expected to permanently eliminate OA pain.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100381"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594423002133/pdfft?md5=a3a63ad00559b7e5aa4ade0c37f3864a&pid=1-s2.0-S2772594423002133-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140190591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.inpm.2024.100401
John Tran , Emma Campisi , Alexandria Roa Agudelo , Anne MR. Agur , Eldon Loh
Objective
Lumbar medial branch denervation is commonly used to treat chronic facetogenic low back pain. Controversy exists regarding risk to adjacent neural structures. The objectives of this cadaveric study were to: (1) dissect, digitize, and model in 3D the branches of the first (L1) to fifth (L5) lumbar dorsal rami located near the junction of the transverse process and lateral neck of the superior articular process; and (2) quantify the minimal distance between the lateral/intermediate and medial branches at the anterior quarter and midpoint of the lateral neck of the superior articular process.
Design
Eighteen formalin-embalmed specimens were dissected, digitized and modeled in 3D. The high-fidelity 3D models were used to compare branching patterns and quantify the mean minimal distance between the lateral/intermediate and medial branches of the lumbar dorsal ramus at the anterior quarter and midpoint of the lateral neck of the superior articular process. A Two-way ANOVA was performed to determine if difference of mean distances was significant.
Results
There was variability in the branching pattern of the lumbar dorsal rami. In 46 cases (51.1%) the lumbar dorsal ramus divided into 2 branches, in 41 cases (45.6%) into 3, and in 3 cases (3.3%) 4. The mean minimal distance between the lateral/intermediate and medial branches was significantly greater at the midpoint (3.2 ± 2.5 mm) than the anterior quarter (1.2 ± 1.8 mm) of the lateral neck of superior articular process.
Conclusion
Minimal distance measurements between the branches of the lumbar dorsal rami at the anterior quarter and midpoint of the lateral neck of the superior articular process were computed. When placing the distal end of the needle tip at the anterior quarter of the lateral neck of the superior articular process, the smaller mean minimal distance between the branches suggests there is a greater risk for inadvertent denervation of the lateral/intermediate branches. Further anatomical and clinical investigations are required.
{"title":"High-fidelity 3D modelling of the lumbar dorsal rami","authors":"John Tran , Emma Campisi , Alexandria Roa Agudelo , Anne MR. Agur , Eldon Loh","doi":"10.1016/j.inpm.2024.100401","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100401","url":null,"abstract":"<div><h3>Objective</h3><p>Lumbar medial branch denervation is commonly used to treat chronic facetogenic low back pain. Controversy exists regarding risk to adjacent neural structures. The objectives of this cadaveric study were to: (1) dissect, digitize, and model in 3D the branches of the first (L1) to fifth (L5) lumbar dorsal rami located near the junction of the transverse process and lateral neck of the superior articular process; and (2) quantify the minimal distance between the lateral/intermediate and medial branches at the anterior quarter and midpoint of the lateral neck of the superior articular process.</p></div><div><h3>Design</h3><p>Eighteen formalin-embalmed specimens were dissected, digitized and modeled in 3D. The high-fidelity 3D models were used to compare branching patterns and quantify the mean minimal distance between the lateral/intermediate and medial branches of the lumbar dorsal ramus at the anterior quarter and midpoint of the lateral neck of the superior articular process. A Two-way ANOVA was performed to determine if difference of mean distances was significant.</p></div><div><h3>Results</h3><p>There was variability in the branching pattern of the lumbar dorsal rami. In 46 cases (51.1%) the lumbar dorsal ramus divided into 2 branches, in 41 cases (45.6%) into 3, and in 3 cases (3.3%) 4. The mean minimal distance between the lateral/intermediate and medial branches was significantly greater at the midpoint (3.2 ± 2.5 mm) than the anterior quarter (1.2 ± 1.8 mm) of the lateral neck of superior articular process.</p></div><div><h3>Conclusion</h3><p>Minimal distance measurements between the branches of the lumbar dorsal rami at the anterior quarter and midpoint of the lateral neck of the superior articular process were computed. When placing the distal end of the needle tip at the anterior quarter of the lateral neck of the superior articular process, the smaller mean minimal distance between the branches suggests there is a greater risk for inadvertent denervation of the lateral/intermediate branches. Further anatomical and clinical investigations are required.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100401"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000219/pdfft?md5=ac2398ce3ed2251a79a4af1baaed29b7&pid=1-s2.0-S2772594424000219-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.inpm.2024.100400
Kelly Li , Annette A. Wang
{"title":"The effectiveness of cervical transforaminal epidural steroid injections for the treatment of cervical radicular pain: A prospective cohort study reporting 12-month outcomes","authors":"Kelly Li , Annette A. Wang","doi":"10.1016/j.inpm.2024.100400","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100400","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100400"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000207/pdfft?md5=8b07a45cdcbd650113039dfe51e26ad8&pid=1-s2.0-S2772594424000207-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-25DOI: 10.1016/j.inpm.2024.100396
R Sterling Haring , D.J. Kennedy , Kristin R. Archer , Valentine U. Chukwuma , Jakob T. Dovgan , Byron J. Schneider
Background
Transforaminal and interlaminar approaches are both common means of performing epidural steroid injection. Comparative effectiveness data on outcomes of these approaches is available but has yielded mixed results.
Objective
Compare the effect of transforaminal vs interlaminar delivery of epidural steroids on patient-reported pain severity.
Design
Retrospective Cohort Study.
Methods
A retrospective review of prospectively collected interventional spine procedure registry data between December 2011 and July 2017 from a single academic medical center. Those who received epidural steroid injections and had prospectively collected index pain data (11-point Numeric Rating Scale [NRS]) recorded in the patient's chart prior to the procedure and at a 3 month follow up appointment were included. The outcome of interest was ≥50% reduction in pain as measured using a NRS for back and/or leg pain. To evaluate true predictive odds of success, multivariable logistic regression modeling was used to determine the odds of achieving improved pain.
Results
Of the 73 patients included in the study, 61 (84%) reported radicular pain, 49 (67%) reported back pain, and eleven (15%) had symptoms consistent with claudication, pain characteristics were not mutually exclusive. Fifty-one (70%) underwent transforaminal epidural steroid injection, while 22 (30%) underwent interlaminar injection. When claudication and radicular pain groups were combined into a single “leg pain” category (n = 66), 26/46 (57% 95% CI 41–71%) patients undergoing transforaminal and 6/20 (30% 95% CI 12–54%) patients undergoing interlaminar injections achieved ≥50% leg pain reduction on NRS (p = 0.048). Transforaminal epidural steroid injections were associated with higher odds of ≥50% reduction in leg pain in both the unadjusted model (OR 3.2, p = 00.034) and after adjustment for presence of radicular pain on presentation and the type of steroid used (OR 3.6, p = 0.042).
Conclusion
In this clinical practice registry, patients treated with transforaminal epidural steroid injection were more likely to achieve ≥50% reduction in radicular or neurogenic/claudicatory leg pain compared to those treated with interlaminar epidural steroid injection.
{"title":"Comparing the clinical outcomes of lumbar transforaminal vs interlaminar epidural steroid injections in a registry cohort","authors":"R Sterling Haring , D.J. Kennedy , Kristin R. Archer , Valentine U. Chukwuma , Jakob T. Dovgan , Byron J. Schneider","doi":"10.1016/j.inpm.2024.100396","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100396","url":null,"abstract":"<div><h3>Background</h3><p>Transforaminal and interlaminar approaches are both common means of performing epidural steroid injection. Comparative effectiveness data on outcomes of these approaches is available but has yielded mixed results.</p></div><div><h3>Objective</h3><p>Compare the effect of transforaminal vs interlaminar delivery of epidural steroids on patient-reported pain severity.</p></div><div><h3>Design</h3><p>Retrospective Cohort Study.</p></div><div><h3>Methods</h3><p>A retrospective review of prospectively collected interventional spine procedure registry data between December 2011 and July 2017 from a single academic medical center. Those who received epidural steroid injections and had prospectively collected index pain data (11-point Numeric Rating Scale [NRS]) recorded in the patient's chart prior to the procedure and at a 3 month follow up appointment were included. The outcome of interest was ≥50% reduction in pain as measured using a NRS for back and/or leg pain. To evaluate true predictive odds of success, multivariable logistic regression modeling was used to determine the odds of achieving improved pain.</p></div><div><h3>Results</h3><p>Of the 73 patients included in the study, 61 (84%) reported radicular pain, 49 (67%) reported back pain, and eleven (15%) had symptoms consistent with claudication, pain characteristics were not mutually exclusive. Fifty-one (70%) underwent transforaminal epidural steroid injection, while 22 (30%) underwent interlaminar injection. When claudication and radicular pain groups were combined into a single “leg pain” category (n = 66), 26/46 (57% 95% CI 41–71%) patients undergoing transforaminal and 6/20 (30% 95% CI 12–54%) patients undergoing interlaminar injections achieved ≥50% leg pain reduction on NRS (p = 0.048). Transforaminal epidural steroid injections were associated with higher odds of ≥50% reduction in leg pain in both the unadjusted model (OR 3.2, p = 00.034) and after adjustment for presence of radicular pain on presentation and the type of steroid used (OR 3.6, p = 0.042).</p></div><div><h3>Conclusion</h3><p>In this clinical practice registry, patients treated with transforaminal epidural steroid injection were more likely to achieve ≥50% reduction in radicular or neurogenic/claudicatory leg pain compared to those treated with interlaminar epidural steroid injection.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100396"},"PeriodicalIF":0.0,"publicationDate":"2024-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000165/pdfft?md5=f9f234b61781685803dff61a9050f0cd&pid=1-s2.0-S2772594424000165-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139945163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-24DOI: 10.1016/j.inpm.2024.100390
Weibin Shi , To-Nhu Vu , Thiru Annaswamy , Hong Wu , Bryan Moore , Nicole Hatchard , Chad Mears , Allen R. Kunselman
Background
Genicular nerve radiofrequency ablation (GNRFA) is a popular and effective procedure to treat arthritic knee pain. For refractory arthritic pain that fails conservative treatment, total knee arthroplasty (TKA) has been an excellent option. Unfortunately, 15–30% of people who undergo a TKA continue to experience pain and stiffness in the knee. The treatment options for post-TKA knee pain are limited. Pain providers have been trialing GNRFA on this pain condition. However, convincing evidence of its efficacy in treating post-TKA pain is still lacking.
Methods
This is a retrospective study of 73 patients who had undergone genicular nerve RFA, 46 (63.01%) with osteoarthritic pain, and 27 (36.99%) with post-TKA pain. We compared the outcomes (pain relief, function, and complications) between these two groups at 3 months and 6 months after RFA.
Results
Before RFA, there was no significant difference in initial pain and functional level between these two groups. After RFA, the two groups had comparable pain relief at 3 months (p = 0.68) and 6 months (p = 0.53), and similar functionality at 3 months (p = 0.36) and 6 months (p = 0.65).
The overall success rate (≥50% pain relief after RFA) was 80.82%, 95% CI: 70.34%–88.22% (osteoarthritic group 80.43%, 95% CI: 66.83%–89.35%, post-TKA 81.48%, 95% CI: 63.30%–91.82%, P = 0.91) at 3-month follow-up and 56.16%, 95% CI: 44.76%–66.95% (osteoarthritic group 56.52%, 95% CI: 42.25%–69.79%, post-TKA 55.56%, 95% CI: 37.31%–72.41%, P = 0.94) at 6-month follow-up.
There were no reported complications in either group.
Conclusions
Genicular Nerve Radiofrequency Ablation (GNRFA) holds the potential to be equally effective for both post-TKA knee pain and osteoarthritic knee pain.
{"title":"Effectiveness comparison of genicular nerve ablation for knee osteoarthritic versus post-total knee arthroplasty pain","authors":"Weibin Shi , To-Nhu Vu , Thiru Annaswamy , Hong Wu , Bryan Moore , Nicole Hatchard , Chad Mears , Allen R. Kunselman","doi":"10.1016/j.inpm.2024.100390","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100390","url":null,"abstract":"<div><h3>Background</h3><p>Genicular nerve radiofrequency ablation (GNRFA) is a popular and effective procedure to treat arthritic knee pain. For refractory arthritic pain that fails conservative treatment, total knee arthroplasty (TKA) has been an excellent option. Unfortunately, 15–30% of people who undergo a TKA continue to experience pain and stiffness in the knee. The treatment options for post-TKA knee pain are limited. Pain providers have been trialing GNRFA on this pain condition. However, convincing evidence of its efficacy in treating post-TKA pain is still lacking.</p></div><div><h3>Methods</h3><p>This is a retrospective study of 73 patients who had undergone genicular nerve RFA, 46 (63.01%) with osteoarthritic pain, and 27 (36.99%) with post-TKA pain. We compared the outcomes (pain relief, function, and complications) between these two groups at 3 months and 6 months after RFA.</p></div><div><h3>Results</h3><p>Before RFA, there was no significant difference in initial pain and functional level between these two groups. After RFA, the two groups had comparable pain relief at 3 months (p = 0.68) and 6 months (p = 0.53), and similar functionality at 3 months (p = 0.36) and 6 months (p = 0.65).</p><p>The overall success rate (≥50% pain relief after RFA) was 80.82%, 95% CI: 70.34%–88.22% (osteoarthritic group 80.43%, 95% CI: 66.83%–89.35%, post-TKA 81.48%, 95% CI: 63.30%–91.82%, P = 0.91) at 3-month follow-up and 56.16%, 95% CI: 44.76%–66.95% (osteoarthritic group 56.52%, 95% CI: 42.25%–69.79%, post-TKA 55.56%, 95% CI: 37.31%–72.41%, P = 0.94) at 6-month follow-up.</p><p>There were no reported complications in either group.</p></div><div><h3>Conclusions</h3><p>Genicular Nerve Radiofrequency Ablation (GNRFA) holds the potential to be equally effective for both post-TKA knee pain and osteoarthritic knee pain.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100390"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000086/pdfft?md5=1ba26cb996d02940c8fb247d35d52424&pid=1-s2.0-S2772594424000086-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139942224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-17DOI: 10.1016/j.inpm.2024.100391
Dharam Persaud-Sharma , Chamara Gunaratne , Jay Talati , Will Philips , Akib Sohel , Andrew Blake , Terrie Vasilopoulos , Sanjeev Kumar
Background
The overall aim of this study was to assess the effectiveness of endoscopic decompression for outcomes in patients with lumbar spinal stenosis (LSS).
Methods
We conducted a retrospective cohort, single-institution study of n = 139 patients from 2019 to 2022 who underwent endoscopic decompression for LSS. The primary outcome was improvement of Oswestry Disability Index (ODI) between baseline and 12-month follow-up.
Results
In the present sample (n = 139) the average age was 57.6 years (SD = 17.4, with even distribution of men (49%) vs. women (51%). In patients with LSS, lumbar disc herniation was the most common diagnosis in 49 patients followed by lumbar radiculopathy in 25 patients. Lumbar radicular pain was the 3rd most common diagnosis in 21 patients with all other diagnosis listed in Table S1. There was a significant improvement (i.e., decrease) in ODI following endoscopic decompression (mean change: −8.3, 95% CI: −9.4, −7.2, P < 0.001, Fig. 1). Prior lumbar spine surgery (P = 0.048), BMI (P = 0.053), and age (P = 0.022) were associated with changes in ODI. Nearly half (47%) of the sample had prior lumbar spine surgery. Those with prior lumbar spine surgery (−7.5, 95% CI: −8.3, −6.6) showed less improvement than those without prior lumbar spine surgery (−9.1, 95% CI: −10.9, −7.2, Fig. 2). For BMI, 23% had normal BMI while 24% were overweight and 53% were obese. Patients with normal BMI (−10.3, 95% CI: −13.4, −7.2) showed greater improvements compared to overweight (−7.9, 95% CI: −9.4, −6.4) and obese (−7.6, 95% CI: −9.0, −6.3, Fig. 3) patients. Patients under 40 years old (−10.2, 95% CI: −13.6, −6.8) showed greater improvements in ODI compared to those 40 years and older (−7.8, 95% CI: −8.6, −6.8, Fig. 4).
Conclusions
In patients with lumbar spinal stenosis, endoscopic decompression was associated with reduced disability. Patients with no prior lumbar spine surgery, normal BMI, and who were under 40 years old showed greater improvements.
{"title":"Efficacy of endoscopic decompression surgery for treatment of lumbar spinal stenosis","authors":"Dharam Persaud-Sharma , Chamara Gunaratne , Jay Talati , Will Philips , Akib Sohel , Andrew Blake , Terrie Vasilopoulos , Sanjeev Kumar","doi":"10.1016/j.inpm.2024.100391","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100391","url":null,"abstract":"<div><h3>Background</h3><p>The overall aim of this study was to assess the effectiveness of endoscopic decompression for outcomes in patients with lumbar spinal stenosis (LSS).</p></div><div><h3>Methods</h3><p>We conducted a retrospective cohort, single-institution study of n = 139 patients from 2019 to 2022 who underwent endoscopic decompression for LSS. The primary outcome was improvement of Oswestry Disability Index (ODI) between baseline and 12-month follow-up.</p></div><div><h3>Results</h3><p>In the present sample (n = 139) the average age was 57.6 years (SD = 17.4, with even distribution of men (49%) vs. women (51%). In patients with LSS, lumbar disc herniation was the most common diagnosis in 49 patients followed by lumbar radiculopathy in 25 patients. Lumbar radicular pain was the 3rd most common diagnosis in 21 patients with all other diagnosis listed in Table S1. There was a significant improvement (i.e., decrease) in ODI following endoscopic decompression (mean change: −8.3, 95% CI: −9.4, −7.2, <em>P</em> < 0.001, Fig. 1). Prior lumbar spine surgery (<em>P</em> = 0.048), BMI (<em>P</em> = 0.053), and age (<em>P</em> = 0.022) were associated with changes in ODI. Nearly half (47%) of the sample had prior lumbar spine surgery. Those with prior lumbar spine surgery (−7.5, 95% CI: −8.3, −6.6) showed less improvement than those without prior lumbar spine surgery (−9.1, 95% CI: −10.9, −7.2, Fig. 2). For BMI, 23% had normal BMI while 24% were overweight and 53% were obese. Patients with normal BMI (−10.3, 95% CI: −13.4, −7.2) showed greater improvements compared to overweight (−7.9, 95% CI: −9.4, −6.4) and obese (−7.6, 95% CI: −9.0, −6.3, Fig. 3) patients. Patients under 40 years old (−10.2, 95% CI: −13.6, −6.8) showed greater improvements in ODI compared to those 40 years and older (−7.8, 95% CI: −8.6, −6.8, Fig. 4).</p></div><div><h3>Conclusions</h3><p>In patients with lumbar spinal stenosis, endoscopic decompression was associated with reduced disability. Patients with no prior lumbar spine surgery, normal BMI, and who were under 40 years old showed greater improvements.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100391"},"PeriodicalIF":0.0,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000098/pdfft?md5=e5c1fe597f6675c092f0539d0265664c&pid=1-s2.0-S2772594424000098-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139749399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-02DOI: 10.1016/j.inpm.2024.100389
Harman Chopra , Melissa Jackels , Michael Suarez , Peter D. Vu , Mustafa Broachwala , Tariq AlFarra , Eellan Sivanesan
Crohn's disease is a chronic inflammatory bowel condition causing symptoms, notably pain, due to ongoing intestinal inflammation or complications like abscesses, strictures, and fistulas, which are common in IBD patients. Abdominal pain affects up to 60 % of IBD patients, irrespective of disease severity, prompting medical attention. Various medications like NSAIDs, antidepressants, antispasmodics, anticonvulsants, and opioids are used to manage pain, but they have limited effectiveness and potential side effects, even during remission. In this case, a 20-year-old Caucasian female college student [height 5′4″, weight 120lbs (54.4 kg)] with juvenile idiopathic arthritis and Crohn's disease experienced severe daily abdominal pain, negatively impacting her life. Despite a multimodal regimen, including gabapentin, nortriptyline, duloxetine, and acetaminophen, her pain persisted, significantly affecting her appetite, sleep, mood, activity level, and overall quality of life (QOL). To address this, dorsal root ganglion (DRG) stimulation was considered. The patient aimed for a 20 % pain reduction and improved QOL. Trial leads were placed along the T10 and T12 DRG, resulting in a 25 % pain reduction (8–6 out of 10) and substantial QOL improvement. She could eat, sleep without interruptions, walk longer distances, and be more active. The T12 lead was more effective than the T10, targeting upper abdomen stimulation. The patient and her mother were highly satisfied and opted for permanent implantation for the T11 and T12 DRG. While DRG stimulation was approved in 2016 for chronic pain, to our knowledge, this is the first reported case of its use in a patient with debilitating Crohn's disease.
{"title":"Dorsal root ganglion stimulation provides significant functional improvement from acute debilitating Crohn's disease: A novel use","authors":"Harman Chopra , Melissa Jackels , Michael Suarez , Peter D. Vu , Mustafa Broachwala , Tariq AlFarra , Eellan Sivanesan","doi":"10.1016/j.inpm.2024.100389","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100389","url":null,"abstract":"<div><p>Crohn's disease is a chronic inflammatory bowel condition causing symptoms, notably pain, due to ongoing intestinal inflammation or complications like abscesses, strictures, and fistulas, which are common in IBD patients. Abdominal pain affects up to 60 % of IBD patients, irrespective of disease severity, prompting medical attention. Various medications like NSAIDs, antidepressants, antispasmodics, anticonvulsants, and opioids are used to manage pain, but they have limited effectiveness and potential side effects, even during remission. In this case, a 20-year-old Caucasian female college student [height 5′4″, weight 120lbs (54.4 kg)] with juvenile idiopathic arthritis and Crohn's disease experienced severe daily abdominal pain, negatively impacting her life. Despite a multimodal regimen, including gabapentin, nortriptyline, duloxetine, and acetaminophen, her pain persisted, significantly affecting her appetite, sleep, mood, activity level, and overall quality of life (QOL). To address this, dorsal root ganglion (DRG) stimulation was considered. The patient aimed for a 20 % pain reduction and improved QOL. Trial leads were placed along the T10 and T12 DRG, resulting in a 25 % pain reduction (8–6 out of 10) and substantial QOL improvement. She could eat, sleep without interruptions, walk longer distances, and be more active. The T12 lead was more effective than the T10, targeting upper abdomen stimulation. The patient and her mother were highly satisfied and opted for permanent implantation for the T11 and T12 DRG. While DRG stimulation was approved in 2016 for chronic pain, to our knowledge, this is the first reported case of its use in a patient with debilitating Crohn's disease.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100389"},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000074/pdfft?md5=0564ebd6fbfad332f1c110baf2076d2b&pid=1-s2.0-S2772594424000074-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-26DOI: 10.1016/j.inpm.2024.100388
Melissa Schwartz , Pranamya Suri , Scott Benkovic , Eric Muneio , Nikhil Gopal , Akhil Chhatre
Phantom and residual limb pain are commonly experienced by the majority of amputees, and are often difficult to treat not adequately relieved with medical treatment alone. While extensively studied, the pathophysiology of refractory pain is still unclear, with many proposed mechanisms under investigation (Wilkes et al., 2008). Limited existing literature suggests percutaneous interventions including radiofrequency ablation (RFA) may be promising treatment modalities for patients who have pain refractory to oral agents (Sperry et al., 2023). We present a patient with persistent phantom limb and cancer-associated acetabular pain following hip disarticulation who underwent sciatic-notch RFA for pain management.
{"title":"Sciatic-nerve radiofrequency ablation for phantom limb pain: A case report","authors":"Melissa Schwartz , Pranamya Suri , Scott Benkovic , Eric Muneio , Nikhil Gopal , Akhil Chhatre","doi":"10.1016/j.inpm.2024.100388","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100388","url":null,"abstract":"<div><p>Phantom and residual limb pain are commonly experienced by the majority of amputees, and are often difficult to treat not adequately relieved with medical treatment alone. While extensively studied, the pathophysiology of refractory pain is still unclear, with many proposed mechanisms under investigation (Wilkes et al., 2008). Limited existing literature suggests percutaneous interventions including radiofrequency ablation (RFA) may be promising treatment modalities for patients who have pain refractory to oral agents (Sperry et al., 2023). We present a patient with persistent phantom limb and cancer-associated acetabular pain following hip disarticulation who underwent sciatic-notch RFA for pain management.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100388"},"PeriodicalIF":0.0,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000062/pdfft?md5=b8bcd1ce3e77904555bf60be6e1be75d&pid=1-s2.0-S2772594424000062-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139652972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-25DOI: 10.1016/j.inpm.2024.100386
Ragav Sharma, Nicholas C. Ketchum, Heather M. Curtiss
{"title":"Fluoroscopic OnabotulinumtoxinA injection for Bertolotti Syndrome in refractory back pain: A letter to the editor","authors":"Ragav Sharma, Nicholas C. Ketchum, Heather M. Curtiss","doi":"10.1016/j.inpm.2024.100386","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100386","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100386"},"PeriodicalIF":0.0,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000049/pdfft?md5=258f10893add996a7b46cc42a7752bcf&pid=1-s2.0-S2772594424000049-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139652973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-23DOI: 10.1016/j.inpm.2024.100383
Patricia Zheng , David Hao , George Christolias , Ben Marshall , Clark C. Smith , Shaan Sudhakaran , Jaymin Patel , Zachary L. McCormick , the International Pain & Spine Intervention Society's Patient Safety Committee
This series of FactFinders presents a brief summary of the evidence and outlines recommendations to improve our understanding and management of patients with potential contraindications to epidural steroid injections.
{"title":"FactFinders for patient safety: Delaying epidural steroid injections: Infection and safe platelet cutoff","authors":"Patricia Zheng , David Hao , George Christolias , Ben Marshall , Clark C. Smith , Shaan Sudhakaran , Jaymin Patel , Zachary L. McCormick , the International Pain & Spine Intervention Society's Patient Safety Committee","doi":"10.1016/j.inpm.2024.100383","DOIUrl":"https://doi.org/10.1016/j.inpm.2024.100383","url":null,"abstract":"<div><p>This series of FactFinders presents a brief summary of the evidence and outlines recommendations to improve our understanding and management of patients with potential contraindications to epidural steroid injections.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100383"},"PeriodicalIF":0.0,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772594424000013/pdfft?md5=721cdad61889b9ddc02fe9a877b1a940&pid=1-s2.0-S2772594424000013-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139549564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}